SeerPharma Pty Ltd :: DISCover web-based training

UK | Singapore | Korea

Valvular Disease: Treatment

Description: The heart has four valves that ensure that blood flows in the correct direction. A defective valve can either fail to close completely and leak (regurgitation), or cannot open completely so that blood pumps through a smaller opening (stenosis). All valves can be affected. This course presents basic medical background information about evaluating the prognosis of valvular disease and outlines treatment options.

COURSE OUTLINE

INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

PROGNOSIS AND NON-PHARMACOLOGICAL TREATMEMT
4. Objectives
5. Prognosis
6. Controlling the Risk Factors
7. Surgical Treatment
8. Progress Check

PHARMACOLOGICAL TREATMEMT
9. Objectives
10. Pharmaceutical Agent Overview
11. Beta Blocker Overview
12. Physiologic Effects of Beta Blockers
13. Beta Blockers: Mechanism of Action
14. Beta Blockers: Pharmacokinetics
15. Beta Blocker Safety Profile and Dosage
16. The Coagulation Cascade
17. Anticoagulant Therapies
18. Calcium Channel Blocker Overview
19. Calcium Channel Blocker Indications and Dosage
20. Cardiac Glycoside Mechanism
21. Physiologic Effects of Cardiac Glycosides
22. Diuretics Effects on Kidney Function
23. Physiologic Effects of Diuretics
24. Diuretic Indications
25. Diuretic Safety and Dosage
26. Progress Check

CONCLUSION
27. Summary

COURSE OBJECTIVES

Students completing this course should be able to:

List the factors involved in evaluating a patient's prognosis
Discuss treatment options for a malfunctioning valve
Describe the coagulant cascade and the types of anticoagulants
Detail the mechanism and profile of various beta blockers
Explain how calcium channel blockers (CCBs) work, and detail their uses
Explore the mechanism of action of cardiac glycosides
Describe the use of diuretics

Home

Training Programs

Upcoming Training

Compliance Consulting

DISCover e-Learning

Modules available

SOPtrain

Quality Management Software

Clinical Trials Software

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.